NCT05254301Completed
Nutrition and LOComotoric Rehabilitation in Long COVID-19
Faster Functional Performance Recovery After Individualized Nutrition Therapy Combined With a Patient-tailored Physical Rehabilitation Program Versus Standard Physiotherapy in Patients With Long COVID: a Pilot Study.
Source: ClinicalTrials.gov · Last updated 8 May 2024
Brief summary (registry, in English)
Long COVID is a new phenomenon, in which individuals who experienced a SARS-CoV-2 infection still experience one or more symptoms, such as exercise intolerance, fatigue and/or muscle pains in addition to other COVID-related symptoms, weeks to months after initial infection. The aim of this pilot-study is to learn about which complaints patients continue to experience after their infection and how this affects their lives to a greater or lesser extent and whether a patient-tailored physical rehabilitation programme combined with individualised nutritional therapy leads to a faster recovery compared to a classic exercise program with the physiotherapist.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 65 (actual)
- First submitted
- 19 Feb 2022
- Start date
- 24 Apr 2022
- Primary completion date
- 30 Jan 2024
- Lead sponsor
- Universitair Ziekenhuis Brussel
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT05254301
What you commit to
- Study type: Interventional
- Participants enrolled: 65
- From 24 Apr 2022 to the primary completion date, 30 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patient currently suffers from any other disease beside long COVID that could explain the symptoms (e.g., fibromyalgia, Sjögren disease, severe anaemia...)
- Patient is unable to undergo a rehabilitation programme due to comorbidities (e.g., major cardiovascular disease such as myocarditis or severe dementia), as decided on by the medical study team members.
- Patient currently benefiting from physiotherapy sessions with focus on motor and/or respiratory therapy for COVID-19 or any other unrelated disease
- Patients with metabolic disorders or severe gastro-intestinal conditions (e.g. short bowel syndrome)
Other
- Patients unable to comprehend oral and/or written instructions, questionnaires in English, French or Dutch.
Who the study is looking for
- Able to understand and sign written consent in Dutch, French or English
- Laboratory (PCR and/or serology) confirmed infection with SARS-CoV-2 less than 12 months ago
- Persisting functional difficulties and symptoms: exercise intolerance and/or fatigue and/or muscle pain beyond 12 weeks beside other COVID-related symptoms (e.g., loss of taste and/or smell)
- Patient affiliated to a social security system
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitair Ziekenhuis Brussel Coordinator of this site? Confirm its status | Brussels | Belgium | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.